I-Mab Operating Income

As of the most recent data (June 2025), IMAB shows a operating income of $-38M. That compares with $-3.2B in the prior-year period — up 98.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMAB's operating income is now $-38M (was $-3.2B) — a 98.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether I-Mab is outperforming or lagging.

Tracking IMAB's operating income over time shows whether I-Mab is scaling, shrinking, or reshaping that part of the business. The current reading is $-38M That compares with $-3.2B in the prior-year period — up 98.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has I-Mab's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-38M) with ownership activity and broader fundamentals.

I-Mab's operating income is $-38M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.